In the early stages of AD, prospective individuals manifest elevated levels of hyperphosphorylated tau in their cerebrospinal fluid, a phenomenon that disrupts microtubules and subsequently affects axonal transport and neural transmission [8], thereby contributing to cognitive decline. The gene discussed is MAPT; the disease is Alzheimer disease.